For pharma and biopharma companies, building quality into your products from an early stage is a key factor in regulatory approval and market success. Thus, the FDA mentions “Design of Experiments” (DoE) as an essential tool for achieving both regulatory compliance and faster time to market.
To help build quality into your process as outlined by ICH Q8, Q9, and Q10, Eminence Business Media is planning a two-day robust training program on “Advance DoE Workshop 2024” on May 9th-10th, 2024 at Hotel Radisson Blu Mumbai International Airport. The program will focus on Implementing Pharma QbD: Recent Paradigms and Techniques of Quintessential DoE.
The trainers will help the participants learn concepts of Advanced Level Statistical Concepts required to Optimize Processes and achieve Product Robustness.
The two-day program will help in learning how to:
- Plan, Design, Conduct, and Analyse experiments efficiently and effectively
- Use response surface methods for system optimization as a follow-up to successful screening.
- Use experimental design tools for computer experiments
- Use software tools to create custom designs based on optimal design methodology
How will it help in your daily work?
More insight and knowledge of the design of experiments leads to improved process variation, performance aligned with planning, shorter development times, more reliability and reduced costs.
What’s Next?
Participants make better choices and schedules for experiments.
Participants can detect and discover interruptions early in the production process.
Participants can interpret test results in a more precise and complete fashion.
Who can Attend?
Key process owners and core team members from the following departments of Pharma and Life Sciences
- Research & Development
- Formulation & Development
- Process Excellence
- Professional scientists, researchers
- Improvement engineers and managers involved in quality engineering
- S.Q.C / S.P.C – production, Laboratory and quality assurance and regulatory affairs
